| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| MORGAN STANLEY | 1.2% | $70,884,406 | 8,471,801 | Morgan Stanley | 31 Mar 2025 |
As of 30 Sep 2025, 7 institutional investors reported holding 58,257 shares of Pharming Group N.V. - Ordinary Shares / American Depositary Shares (PHAR). This represents 0.01% of the company’s total 705,983,417 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 50,547 | $893,165 | -$28,272 | $17.67 | 1 |
| 2025 Q3 | 58,257 | $844,731 | +$1,902 | $14.50 | 7 |
| 2025 Q2 | 58,026 | $620,298 | +$75,323 | $10.69 | 3 |
| 2025 Q1 | 51,003 | $426,701 | -$1,676 | $8.37 | 3 |
| 2024 Q4 | 51,101 | $514,333 | +$64,544 | $10.07 | 5 |
| 2024 Q3 | 44,747 | $369,164 | +$138,704 | $8.25 | 4 |
| 2024 Q2 | 27,592 | $230,393 | +$58,701 | $8.35 | 4 |
| 2024 Q1 | 20,562 | $215,901 | +$546 | $10.50 | 3 |
| 2023 Q4 | 20,510 | $234,429 | -$133,551 | $11.43 | 2 |
| 2023 Q3 | 14,215 | $162,051 | +$133,551 | $11.40 | 2 |
| 2023 Q2 | 24,960 | $290,784 | -$11,894 | $11.65 | 2 |
| 2023 Q1 | 25,841 | $295,644 | -$51,545 | $13.50 | 3 |
| 2022 Q4 | 29,510 | $325,137 | +$49,840 | $11.03 | 3 |
| 2022 Q3 | 24,984 | $245,000 | +$44,126 | $9.78 | 3 |
| 2022 Q2 | 20,472 | $180,000 | -$1,433 | $8.80 | 3 |
| 2022 Q1 | 20,586 | $184,000 | +$17,832 | $8.88 | 4 |
| 2021 Q4 | 18,628 | $166,000 | -$77,219 | $8.92 | 3 |
| 2021 Q3 | 26,355 | $249,000 | -$1,873,742 | $9.46 | 4 |
| 2021 Q2 | 198,455 | $2,238,000 | +$230,931 | $11.27 | 7 |
| 2021 Q1 | 192,149 | $2,465,000 | -$21,866,866 | $12.83 | 3 |
| 2020 Q4 | 1,896,857 | $2,963,000 | +$2,962,947 | $8.42 | 2 |
| 2020 Q2 | 16,500 | $145,000 | $0 | $8.79 | 1 |